Back to Journals » Clinical Ophthalmology » Volume 8

Navigated focal laser photocoagulation for central serous chorioretinopathy

Authors Chhablani J, Rani PK, Mathai A, Jalali S, Kozak I

Received 30 April 2014

Accepted for publication 19 May 2014

Published 18 August 2014 Volume 2014:8 Pages 1543—1547

DOI https://doi.org/10.2147/OPTH.S67025

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4


Jay Chhablani,1 Padmaja Kumari Rani,1 Annie Mathai,1 Subhadra Jalali,1 Igor Kozak2

1Srimati Kanuri Santhamma Vitreo-Retina Service, L V Prasad Eye Institute, Hyderabad, India; 2Division of Vitreoretinal Diseases and Surgery, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia

Background and objective: To assess the efficacy of navigated laser (Navilas®) treatment for central serous chorioretinopathy.
Materials and methods: Prospective study included 16 eyes of 15 subjects with nonresolving central serous chorioretinopathy. Fluorescein-angiography guided Navilas® treatment was performed. Pre- and posttreatment best-corrected visual acuity, pre- and posttreatment central macular thickness, number of leaks on fluorescein angiography, and various treatment parameters were analyzed. Pain experience was evaluated using the visual analog pain scale.
Results: Sixteen eyes from 15 subjects (mean age 42.2±9.9 years) were analyzed. Mean duration of symptoms was 11.45±6.6 months. Average number of leaks per eye was 2.8 and one laser spot per leak was performed. There was complete resolution of subretinal fluid in 15 out of 16 eyes at 2 months. Average visual analog pain scale score was 0.63±1.41.
Conclusion: Navilas® without a contact lens achieved resolution of subretinal fluid with a single laser spot for each single leak and minimum iatrogenic damage.

Keywords: navigated laser, Navilas®


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]